Nozha International Hospital (EGX:NINH)

CTI BioPharma Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,854	1,980	1,498	1,121	949	703
Market Cap Growth	31.70%	32.21%	33.65%	18.06%	35.00%	38.52%
Enterprise Value	1,702	1,709	1,270	893	755	565
Last Close Price	7.66	8.09	6.12	4.58	3.86	2.85
PE Ratio	15.60	18.24	17.95	19.79	15.81	15.60
PS Ratio	4.09	4.58	4.13	3.79	3.79	3.24
PB Ratio	3.18	3.45	3.23	2.95	2.90	2.58
P/TBV Ratio	3.19	3.45	3.23	2.96	2.91	2.58
P/FCF Ratio	15.72	25.71	84.82	43.48	14.18	19.05
P/OCF Ratio	13.62	16.14	13.84	19.87	11.99	14.63
EV/Sales Ratio	3.75	3.95	3.50	3.02	3.01	2.60
EV/EBITDA Ratio	14.90	16.02	13.97	13.21	9.64	9.57
EV/EBIT Ratio	16.36	17.66	15.26	14.55	10.47	10.77
EV/FCF Ratio	14.44	22.19	71.91	34.66	11.28	15.31
Debt / Equity Ratio	0	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.00	0.00	0.00	0.01	0.01	0.01
Debt / FCF Ratio	0.00	0.00	0.02	0.02	0.01	0.01
Asset Turnover	0.71	0.72	0.74	0.72	0.70	0.71
Inventory Turnover	10.62	10.57	11.16	12.35	9.88	8.83
Quick Ratio	2.00	4.71	4.18	5.32	4.87	4.12
Current Ratio	3.92	5.12	4.55	5.79	5.22	4.54
Return on Equity (ROE)	24.08%	22.66%	21.68%	17.96%	21.95%	19.52%
Return on Assets (ROA)	10.12%	10.08%	10.63%	9.35%	12.66%	10.69%
Return on Capital (ROIC)	12.17%	11.65%	12.31%	10.84%	14.98%	12.89%
Return on Capital Employed (ROCE)	17.70%	16.80%	17.80%	16.00%	21.80%	19.00%
Earnings Yield	6.41%	5.94%	6.11%	5.67%	6.94%	7.05%
FCF Yield	6.36%	3.89%	1.18%	2.30%	7.05%	5.25%
Dividend Yield	1.19%	1.12%	-	-	0.56%	-
Payout Ratio	9.69%	6.85%	7.53%	17.41%	13.28%	23.48%
Buyback Yield / Dilution	-	-	0.00%	0.00%	0.00%	-
Total Shareholder Return	1.18%	1.12%	-	0.00%	0.56%	-

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.